Logo image of CLB

CORE LABORATORIES INC (CLB) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CLB - US21867A1051 - Common Stock

19.43 USD
-0.19 (-0.97%)
Last: 1/16/2026, 8:04:00 PM
19.43 USD
0 (0%)
After Hours: 1/16/2026, 8:04:00 PM
Fundamental Rating

5

CLB gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 62 industry peers in the Energy Equipment & Services industry. CLB has an excellent financial health rating, but there are some minor concerns on its profitability. CLB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • CLB had positive earnings in the past year.
  • In the past year CLB had a positive cash flow from operations.
  • Of the past 5 years CLB 4 years were profitable.
  • CLB had a positive operating cash flow in each of the past 5 years.
CLB Yearly Net Income VS EBIT VS OCF VS FCFCLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

  • CLB's Return On Assets of 5.43% is fine compared to the rest of the industry. CLB outperforms 70.97% of its industry peers.
  • CLB has a better Return On Equity (11.84%) than 75.81% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 9.29%, CLB is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CLB is below the industry average of 12.77%.
  • The 3 year average ROIC (8.80%) for CLB is below the current ROIC(9.29%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.43%
ROE 11.84%
ROIC 9.29%
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
CLB Yearly ROA, ROE, ROICCLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

  • With a decent Profit Margin value of 6.21%, CLB is doing good in the industry, outperforming 62.90% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CLB has declined.
  • CLB has a Operating Margin of 11.16%. This is in the better half of the industry: CLB outperforms 61.29% of its industry peers.
  • In the last couple of years the Operating Margin of CLB has declined.
  • Looking at the Gross Margin, with a value of 19.95%, CLB is doing worse than 69.35% of the companies in the same industry.
  • CLB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.16%
PM (TTM) 6.21%
GM 19.95%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
CLB Yearly Profit, Operating, Gross MarginsCLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLB is still creating some value.
  • The number of shares outstanding for CLB remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for CLB has been increased compared to 5 years ago.
  • The debt/assets ratio for CLB has been reduced compared to a year ago.
CLB Yearly Shares OutstandingCLB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CLB Yearly Total Debt VS Total AssetsCLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • CLB has an Altman-Z score of 3.57. This indicates that CLB is financially healthy and has little risk of bankruptcy at the moment.
  • CLB has a better Altman-Z score (3.57) than 80.65% of its industry peers.
  • The Debt to FCF ratio of CLB is 3.32, which is a good value as it means it would take CLB, 3.32 years of fcf income to pay off all of its debts.
  • CLB has a Debt to FCF ratio of 3.32. This is in the better half of the industry: CLB outperforms 64.52% of its industry peers.
  • CLB has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
  • CLB has a Debt to Equity ratio (0.42) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.32
Altman-Z 3.57
ROIC/WACC1.06
WACC8.73%
CLB Yearly LT Debt VS Equity VS FCFCLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 2.37 indicates that CLB has no problem at all paying its short term obligations.
  • CLB's Current ratio of 2.37 is fine compared to the rest of the industry. CLB outperforms 69.35% of its industry peers.
  • A Quick Ratio of 1.76 indicates that CLB should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.76, CLB is doing good in the industry, outperforming 67.74% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 1.76
CLB Yearly Current Assets VS Current LiabilitesCLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

  • The earnings per share for CLB have decreased by -9.41% in the last year.
  • The earnings per share for CLB have been decreasing by -13.14% on average. This is quite bad
  • CLB shows a decrease in Revenue. In the last year, the revenue decreased by -1.02%.
  • CLB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.75% yearly.
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.78% on average over the next years. This is quite good.
  • CLB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.47% yearly.
EPS Next Y-15.64%
EPS Next 2Y-7.43%
EPS Next 3Y2.56%
EPS Next 5Y12.78%
Revenue Next Year-1.75%
Revenue Next 2Y-1.26%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CLB Yearly Revenue VS EstimatesCLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
CLB Yearly EPS VS EstimatesCLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 25.23, the valuation of CLB can be described as expensive.
  • CLB's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of CLB to the average of the S&P500 Index (27.38), we can say CLB is valued inline with the index average.
  • A Price/Forward Earnings ratio of 25.76 indicates a quite expensive valuation of CLB.
  • CLB's Price/Forward Earnings is on the same level as the industry average.
  • CLB is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 24.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.23
Fwd PE 25.76
CLB Price Earnings VS Forward Price EarningsCLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 80.65% of the companies in the same industry are cheaper than CLB, based on the Enterprise Value to EBITDA ratio.
  • CLB's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 26.31
EV/EBITDA 13.71
CLB Per share dataCLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.43%
EPS Next 3Y2.56%

3

5. Dividend

5.1 Amount

  • CLB has a yearly dividend return of 0.20%, which is pretty low.
  • CLB's Dividend Yield is comparable with the industry average which is at 1.17.
  • With a Dividend Yield of 0.20, CLB pays less dividend than the S&P500 average, which is at 1.85.
Industry RankSector Rank
Dividend Yield 0.2%

5.2 History

  • The dividend of CLB decreases each year by -55.13%.
  • CLB has paid a dividend for at least 10 years, which is a reliable track record.
  • CLB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-55.13%
Div Incr Years0
Div Non Decr Years3
CLB Yearly Dividends per shareCLB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • 5.83% of the earnings are spent on dividend by CLB. This is a low number and sustainable payout ratio.
DP5.83%
EPS Next 2Y-7.43%
EPS Next 3Y2.56%
CLB Yearly Income VS Free CF VS DividendCLB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
CLB Dividend Payout.CLB Dividend Payout, showing the Payout Ratio.CLB Dividend Payout.PayoutRetained Earnings

CORE LABORATORIES INC

NYSE:CLB (1/16/2026, 8:04:00 PM)

After market: 19.43 0 (0%)

19.43

-0.19 (-0.97%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)10-22
Earnings (Next)01-29
Inst Owners113.63%
Inst Owner Change1.41%
Ins Owners1.02%
Ins Owner Change7.46%
Market Cap904.66M
Revenue(TTM)517.50M
Net Income(TTM)32.12M
Analysts48
Price Target16.15 (-16.88%)
Short Float %9.28%
Short Ratio8.48
Dividend
Industry RankSector Rank
Dividend Yield 0.2%
Yearly Dividend0.04
Dividend Growth(5Y)-55.13%
DP5.83%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.26%
Min EPS beat(2)-0.33%
Max EPS beat(2)12.86%
EPS beat(4)1
Avg EPS beat(4)1.9%
Min EPS beat(4)-4.67%
Max EPS beat(4)12.86%
EPS beat(8)4
Avg EPS beat(8)4.82%
EPS beat(12)7
Avg EPS beat(12)5.16%
EPS beat(16)8
Avg EPS beat(16)3.39%
Revenue beat(2)2
Avg Revenue beat(2)0.73%
Min Revenue beat(2)0.02%
Max Revenue beat(2)1.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.96%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)1.44%
Revenue beat(8)3
Avg Revenue beat(8)-0.5%
Revenue beat(12)4
Avg Revenue beat(12)-1.2%
Revenue beat(16)5
Avg Revenue beat(16)-1.06%
PT rev (1m)3.26%
PT rev (3m)15.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.66%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.52%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.77%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)1.29%
Valuation
Industry RankSector Rank
PE 25.23
Fwd PE 25.76
P/S 1.75
P/FCF 26.31
P/OCF 18.2
P/B 3.33
P/tB 5.48
EV/EBITDA 13.71
EPS(TTM)0.77
EY3.96%
EPS(NY)0.75
Fwd EY3.88%
FCF(TTM)0.74
FCFY3.8%
OCF(TTM)1.07
OCFY5.49%
SpS11.11
BVpS5.83
TBVpS3.55
PEG (NY)N/A
PEG (5Y)N/A
Graham Number10.05
Profitability
Industry RankSector Rank
ROA 5.43%
ROE 11.84%
ROCE 11.66%
ROIC 9.29%
ROICexc 9.8%
ROICexgc 12.66%
OM 11.16%
PM (TTM) 6.21%
GM 19.95%
FCFM 6.64%
ROA(3y)4.98%
ROA(5y)0.23%
ROE(3y)13.12%
ROE(5y)-16.91%
ROIC(3y)8.8%
ROIC(5y)8.69%
ROICexc(3y)9.11%
ROICexc(5y)8.99%
ROICexgc(3y)11.75%
ROICexgc(5y)11.63%
ROCE(3y)11.03%
ROCE(5y)10.9%
ROICexgc growth 3Y11.32%
ROICexgc growth 5Y-6.37%
ROICexc growth 3Y11.52%
ROICexc growth 5Y-2.86%
OM growth 3Y7.68%
OM growth 5Y-4.33%
PM growth 3Y12.69%
PM growth 5Y-17.05%
GM growth 3Y-3.24%
GM growth 5Y-5.25%
F-Score7
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.32
Debt/EBITDA 1.58
Cap/Depr 104.6%
Cap/Sales 2.96%
Interest Coverage 6.66
Cash Conversion 68.62%
Profit Quality 107.03%
Current Ratio 2.37
Quick Ratio 1.76
Altman-Z 3.57
F-Score7
WACC8.73%
ROIC/WACC1.06
Cap/Depr(3y)71.15%
Cap/Depr(5y)68.67%
Cap/Sales(3y)2.22%
Cap/Sales(5y)2.39%
Profit Quality(3y)84.24%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.41%
EPS 3Y7.42%
EPS 5Y-13.14%
EPS Q2Q%-12%
EPS Next Y-15.64%
EPS Next 2Y-7.43%
EPS Next 3Y2.56%
EPS Next 5Y12.78%
Revenue 1Y (TTM)-1.02%
Revenue growth 3Y3.66%
Revenue growth 5Y-4.75%
Sales Q2Q%0.09%
Revenue Next Year-1.75%
Revenue Next 2Y-1.26%
Revenue Next 3Y-1.03%
Revenue Next 5Y3.47%
EBIT growth 1Y-6.83%
EBIT growth 3Y11.62%
EBIT growth 5Y-8.87%
EBIT Next Year11.19%
EBIT Next 3Y8.03%
EBIT Next 5Y17.46%
FCF growth 1Y286.32%
FCF growth 3Y23.36%
FCF growth 5Y-8.39%
OCF growth 1Y165.78%
OCF growth 3Y15.5%
OCF growth 5Y-8.83%

CORE LABORATORIES INC / CLB FAQ

Can you provide the ChartMill fundamental rating for CORE LABORATORIES INC?

ChartMill assigns a fundamental rating of 5 / 10 to CLB.


Can you provide the valuation status for CORE LABORATORIES INC?

ChartMill assigns a valuation rating of 2 / 10 to CORE LABORATORIES INC (CLB). This can be considered as Overvalued.


Can you provide the profitability details for CORE LABORATORIES INC?

CORE LABORATORIES INC (CLB) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for CLB stock?

The Price/Earnings (PE) ratio for CORE LABORATORIES INC (CLB) is 25.23 and the Price/Book (PB) ratio is 3.33.


What is the expected EPS growth for CORE LABORATORIES INC (CLB) stock?

The Earnings per Share (EPS) of CORE LABORATORIES INC (CLB) is expected to decline by -15.64% in the next year.